Insiders

May. 26 Zealand Pharma A/S Elects Camilla Sylvest to the Board of Directors CI
Apr. 14 Zealand Pharma A/S Announces the Appointment of Eric Rojas as Head of Investor Relations, Effective April 15, 2026 CI
Mar. 26 Zealand Pharma A/S Approves Management Changes CI
Feb. 24 N4 Pharma Names Zealand Pharma CEO to Same Role MT
25-05-20 Danish Biotech Zealand Pharma Names Chief Development Officer MT
25-05-19 Zealand Pharma A/S Appoints Steven Johnson as Chief Development Officer CI
25-04-23 Zealand Pharma Name Utpal Singh Chief Scientific Officer RE
25-04-23 Zealand Pharma A/S Appoints Utpal Singh as Chief Scientific Officer CI
25-03-27 Zealand Pharma A/S Announces Committee Changes CI
24-07-30 Zealand Pharma Names Chief Commercial Officer MT
24-07-29 Zealand Pharma A/S Appoints Eric Cox as Chief Commercial Officer, Effective August 5, 2024 CI
24-03-20 Zealand Pharma A/S Approves Appointments to the Board CI
24-03-13 Zealand Pharma A/S Announces Board Changes CI
23-11-30 Zealand Pharma A/S Appoints Enrique Conterno and Elaine Sullivan as Board Observers CI
23-03-29 Zealand Pharma A/S Announces Committee Appointments CI
22-08-24 Zealand Pharma Appoints New CFO MT
22-08-24 Zealand Pharma Names Henriette Wennicke Finance Chief MT
22-06-02 Zealand Pharma Names David Kendall Chief Medical Officer MT
22-06-02 Zealand Pharma Announces Appoints David M. Kendall, as Chief Medical Officer CI
22-03-30 Zealand Pharma Names New CEO, Cuts US Workforce by 90%; Releases Revised Guidance; Shares Rise MT
22-03-30 Zealand Pharma Announces CEO Changes CI
21-09-01 Zealand Pharma A/S Announces Executive Changes CI
21-08-13 Gertrude Koefoed Rasmussen to Step Down from the Board of Zealand Pharma A/S, Effective as of 31 August 2021 CI
21-05-12 Zealand Pharma A/S Announces the Promotion of Christina Sonnenborg Bredal to Head of People & Organization CI
21-04-15 Zealand Pharma A/S Establishes New Scientific Committee, Which Will Comprise of Kirsten Aarup Drejer as the Chair, Michael John Owen and Alain Munoz as Members of the Committee CI
No results match your criteria
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!